Skip to content

Mast Cell Activation Syndrome (MCAS)

All disabled people have the right to the highest attainable standard of health without discrimination. This page centers disabled people’s expertise and is informed by disabled-led organizing globally.


Mast Cell Activation Syndrome (MCAS) is a condition where your mast cells—immune cells found throughout your body—release their chemicals (including histamine) inappropriately, causing reactions that can affect your skin, digestive system, cardiovascular system, respiratory system, and nervous system all at once.

If you have MCAS, you might react to foods you’ve eaten safely for years, break out in hives from heat or pressure, feel your heart racing after eating, or experience sudden difficulty breathing from fragrances. One day you can tolerate something; the next day it makes you sick. This unpredictability is isolating and confusing—both for you and for people trying to understand.

MCAS is controversial in the medical community. Competing diagnostic criteria mean some doctors believe it’s rare while others believe it’s significantly under-recognized. This leaves patients stuck in the middle, often dismissed as having “just allergies” or “anxiety” when their symptoms are much more complex and disabling.

What makes MCAS particularly important is that it frequently occurs with other conditions—especially Postural Orthostatic Tachycardia Syndrome (POTS) and Ehlers-Danlos Syndromes (EDS). When you have two or three of these conditions together (called “the trifecta”), each one makes the others worse, and treatment needs to address all of them.

If you’re reading this because you suspect MCAS, or you’ve been diagnosed: you’re not imagining your reactions, you’re not “just anxious,” and you deserve medical care that takes your symptoms seriously.


Medical definition: Mast Cell Activation Syndrome is a condition in which mast cells release excessive amounts of inflammatory mediators (chemicals like histamine, tryptase, prostaglandins, leukotrienes, and others) without appropriate triggers, causing chronic multi-system symptoms.

In plain language: Mast cells are immune cells scattered throughout your body, especially in tissues that interact with the outside world—your skin, digestive tract, lungs, and blood vessels. When working properly, they protect you by releasing chemicals that cause inflammation to fight infections or injuries.

In MCAS, these cells release their chemicals too easily, causing allergic-type reactions to things that shouldn’t trigger reactions: foods you’ve eaten safely before, temperature changes, stress, pressure on your skin, or no identifiable trigger at all.

Mast cells release over 1,000 different chemicals. This is why MCAS symptoms are so varied and can affect so many body systems at once.


MCAS is legitimately controversial in medicine, and understanding why helps you navigate the medical system:

Vienna Consensus Criteria (2012)—Strict approach: Requires ALL THREE:

  1. Episodic symptoms affecting ≥2 organ systems
  2. Laboratory evidence: Substantial transient increase in serum tryptase (≥20% above baseline + 2 ng/mL) during symptomatic episode
  3. Response to mast cell-targeted therapies

“Consensus-2” Alternative Criteria (2020)—Broader approach: Proposed by Dr. Lawrence Afrin and colleagues, arguing Vienna criteria lead to under-diagnosis because:

  • Tryptase doesn’t always elevate in MCAS
  • Testing must occur during a reaction (hard to time)
  • Many mediators have very short half-lives
  • Some doctors think MCAS is very rare (only confirmed by strict Vienna criteria)
  • Other doctors think MCAS is significantly under-recognized (affecting up to 17% of people)
  • The truth likely lies somewhere between
  • You may be dismissed by doctors who think MCAS is over-diagnosed
  • You may struggle to get proper testing from doctors who don’t recognize MCAS at all

MCAS only received an ICD-10 code in October 2016, so it’s a relatively recent formal recognition in medical coding systems.


MCAS is part of a spectrum of mast cell disorders:

ConditionMast Cell NumberClonal?Key Feature
MCAS (Idiopathic)NormalNoInappropriate activation, unknown cause
MCAS (Secondary)NormalNoTriggered by allergies, autoimmune conditions, infections
MCAS (Clonal)Normal-elevatedYesKIT mutation present; mast cells are abnormal
Systemic MastocytosisElevatedYesAccumulation of abnormal mast cells in bone marrow/organs
Hereditary Alpha-TryptasemiaNormalNoExtra copies of TPSAB1 gene; elevated baseline tryptase; affects ~4-6% of population

Your doctor may need to rule out systemic mastocytosis (which is serious and requires different treatment) before diagnosing MCAS.


Skin:

  • Flushing (sudden redness, often face/chest)
  • Hives (urticaria)
  • Angioedema (deeper swelling, especially face/lips/throat)
  • Itching—sometimes severe, sometimes no visible rash
  • Dermographism (“skin writing”—scratching leaves raised red marks)

Gastrointestinal:

  • Abdominal cramping and pain
  • Diarrhea or constipation
  • Nausea
  • Bloating
  • GERD (reflux)
  • Food intolerances that seem to change over time

Cardiovascular:

  • Tachycardia (rapid heart rate)
  • Hypotension (low blood pressure)
  • Fainting or near-fainting
  • Palpitations
  • Chest discomfort

Neurological:

  • “Brain fog”—difficulty concentrating, memory problems
  • Headaches and migraines
  • Anxiety (as a physical symptom of mast cell mediator release, not purely psychological)
  • Difficulty finding words

Respiratory:

  • Shortness of breath
  • Wheezing
  • Nasal congestion
  • Throat tightness

Systemic:

  • Fatigue—profound and not relieved by rest
  • Temperature dysregulation
  • Anaphylaxis or anaphylactoid reactions (can be life-threatening)

The pattern: Symptoms often occur in clusters—you might experience flushing, rapid heartbeat, nausea, and brain fog all at once when triggered.


Foods:

  • High-histamine foods (aged cheeses, fermented foods, leftovers, processed meats, alcohol)
  • Histamine-releasing foods (strawberries, citrus, tomatoes, chocolate)
  • Foods you previously tolerated (triggers can change)

Environmental:

  • Fragrances—perfumes, air fresheners, scented cleaning products, laundry detergants
  • Chemicals—paint fumes, new carpet, cleaning supplies
  • Temperature extremes—heat often worse than cold
  • Sudden temperature changes

Physical:

  • Pressure on skin
  • Vibration
  • Friction
  • Exercise (though gentle exercise often helps)

Biological:

  • Stress—emotional and physical
  • Infections and illnesses
  • Menstrual cycle
  • Lack of sleep

Medications:

  • NSAIDs (ibuprofen, aspirin)—common trigger
  • Opioids
  • Contrast dyes used in medical imaging
  • Some antibiotics
  • Alcohol

Think of your tolerance as a bucket. Each trigger adds histamine or mast cell mediators to the bucket:

  • One trigger alone might not cause symptoms
  • Multiple triggers at once fill the bucket until it overflows
  • This explains why you can eat a food one day but react to it another day
  • Keeping your overall “load” low helps prevent reactions

Primary diagnostic tests:

  1. Serum tryptase:

    • Most specific marker for mast cell activation
    • Must compare baseline tryptase (when feeling well) to acute tryptase (within 1-4 hours of symptom flare)
    • Looking for increase of ≥20% + 2 ng/mL
    • Challenge: Must get lab draw during a reaction
  2. 24-hour urine tests:

    • N-methyl histamine
    • Prostaglandin D2 (PGD2)
    • Leukotriene E4
    • Collect urine for full 24 hours during/after symptoms
  3. Bone marrow biopsy (when mastocytosis is suspected)

Key diagnostic challenges:

  • Many mediators have very short half-lives
  • Testing must occur during/immediately after symptoms
  • Results may be normal between episodes
  • Different mediators elevate in different people
  • Allergists/immunologists (most common)
  • Hematologists (especially if mastocytosis suspected)
  • Dermatologists (if skin symptoms prominent)
  • Gastroenterologists (if GI symptoms prominent)

Finding knowledgeable doctors: Patient organizations maintain provider directories. Look for doctors familiar with “mast cell activation syndrome” specifically—many allergists focus on traditional allergies and may not recognize MCAS.

Keep detailed records:

  • Symptom diary noting triggers, timing, severity, body systems affected
  • Food diary
  • Photos of visible symptoms (rashes, flushing, angioedema)
  • Document what helps and what makes things worse

Before appointments:

  • Bring your symptom records
  • List all triggers you’ve identified
  • List all medications and supplements (including what helped and what made things worse)
  • Bring educational materials about MCAS if your doctor is unfamiliar

Critical point: No FDA-approved medications specifically for MCAS exist. Treatment is individualized, often involving trial-and-error to find what works for you.

H1 Antihistamines (block histamine at H1 receptors):

  • Cetirizine (Zyrtec)
  • Fexofenadine (Allegra)
  • Loratadine (Claritin)
  • Dosing: Often need 2-4 times the standard dose (work with your doctor)

H2 Antihistamines (block histamine at H2 receptors—mostly in stomach):

  • Famotidine (Pepcid)
  • Cimetidine (Tagamet)

Why both types: Histamine receptors are found throughout the body. H1 blockers help skin, respiratory, and nervous system symptoms. H2 blockers help GI symptoms and cardiovascular issues. Using both together is often more effective than either alone.

Cromolyn sodium (Gastrocrom, Nasalcrom):

  • Prevents mast cells from releasing their mediators
  • Oral form (Gastrocrom) taken 4 times daily, 15-20 minutes before meals
  • Works primarily in GI tract when taken orally
  • May take several weeks to see full benefit
  • Some people compound it as a solution for broader absorption

Ketotifen:

  • Dual action: antihistamine + mast cell stabilizer
  • Not FDA-approved in US; must be compounded by pharmacy or obtained from other countries
  • Must start at very low dose and increase slowly (can cause drowsiness initially)

Natural mast cell stabilizers (varying levels of evidence):

  • Quercetin: Bioflavonoid with mast cell stabilizing properties
  • Luteolin: Another bioflavonoid
  • Vitamin C: Helps degrade histamine
  • Work with provider on dosing

Leukotriene receptor antagonists:

  • Montelukast (Singulair)
  • Helps with respiratory symptoms and inflammation

For severe/refractory cases:

  • Omalizumab (Xolair): Biologic medication; off-label for MCAS; expensive but can be effective
  • Low-dose aspirin (if tolerated—many MCAS patients cannot tolerate)
  • Immunosuppressants in specific cases

High-histamine foods to limit/avoid:

  • Aged cheeses
  • Fermented foods (sauerkraut, kimchi, yogurt, kombucha)
  • Processed meats (salami, bacon, hot dogs)
  • Alcohol (especially red wine)
  • Leftovers (histamine increases as food ages)
  • Canned fish
  • Vinegar (except white vinegar)
  • Many “health” foods are high-histamine (bone broth, fermented foods marketed as gut-healthy)

Histamine-releasing foods:

  • Strawberries
  • Citrus fruits
  • Tomatoes
  • Chocolate
  • Shellfish
  • Egg whites
  • Pineapple

Lower-histamine foods:

  • Fresh meat, poultry, fish (freeze immediately if not eating same day)
  • Most fresh fruits (except strawberries, citrus, pineapple)
  • Most fresh vegetables (except tomatoes, spinach, eggplant)
  • Rice, quinoa, oats
  • Fresh dairy (if tolerated)
  • Olive oil, coconut oil

Key principles:

  • Fresh is best—histamine increases as food ages
  • Freeze leftovers immediately
  • Avoid canned or processed foods
  • Cook from scratch when possible
  • Keep a food diary to identify personal triggers

Important caveat: Low-histamine diets are restrictive. Work with a dietitian to ensure nutritional adequacy. The goal is to identify triggers, not to restrict forever.


MCAS very frequently occurs with two other conditions:

  • 48% of people with hEDS have MCAS
  • 31% of people with both POTS and EDS also have MCAS (compared to only 2% of POTS patients without EDS)
  • Having all three is so common it’s called “the trifecta”

Why they occur together:

Current research suggests that abnormal connective tissue in Ehlers-Danlos Syndrome affects mast cell stability. Faulty collagen may make mast cells more “fragile” and likely to release their mediators inappropriately. The same connective tissue problems also lead to:

  • Blood vessel laxity causing POTS
  • Increased mast cell activation causing MCAS

The 2025 American Gastroenterological Association issued guidance: When doctors see one of these conditions, they should screen for the others.

See:

When you have multiple conditions:

  • Treatments for one condition may affect others
  • POTS treatments (increased salt and fluids) may help MCAS
  • MCAS treatments (antihistamines) may help POTS
  • Physical therapy for EDS must account for MCAS fatigue and post-exertional malaise
  • Comprehensive treatment plan needs to address all conditions

At home:

  • Use fragrance-free products (laundry detergent, soap, cleaning supplies)
  • Avoid air fresheners, candles, plugins
  • Consider air purifier with HEPA filter
  • Control temperature (keep cool if heat is a trigger)
  • Wash new clothes before wearing
  • Choose natural materials when possible

When going out:

  • Carry antihistamines and epinephrine auto-injectors
  • Avoid heavily scented stores (cosmetics, candles, some clothing stores)
  • Sit away from fragrances in restaurants
  • Have a plan for leaving if you’re triggered

At work/school:

  • Request fragrance-free workplace policies (reasonable accommodation)
  • Explain to coworkers (without requiring them to change personal products, focus on shared spaces)
  • Keep safe snacks at desk
  • Have emergency medications accessible

See Workplace Accommodations.

Meal planning:

  • Cook larger batches and freeze in individual portions immediately
  • Label and date frozen food
  • Thaw in refrigerator, not counter
  • Use a food diary to track reactions
  • Identify safe “go-to” meals

Eating out:

  • Choose restaurants carefully (avoid buffets, sushi bars with old fish)
  • Order simply cooked food
  • Avoid sauces (may contain aged ingredients)
  • Explain you have “food allergies” (easier than explaining MCAS)

MCAS can cause anaphylaxis. All MCAS patients should:

  • Carry two epinephrine auto-injectors (EpiPen, Auvi-Q, generic) at all times
  • Wear medical alert jewelry stating “Mast Cell Activation Syndrome” and “Anaphylaxis Risk”
  • Have emergency action plan
  • Teach family/friends/coworkers how to use epinephrine
  • Know symptoms requiring immediate emergency care:
    • Difficulty breathing
    • Throat tightness
    • Severe drop in blood pressure
    • Loss of consciousness
    • Severe multi-system symptoms

Call 911 (or your country’s emergency number) if you use epinephrine. You need medical monitoring even if symptoms improve.

Common experiences:

  • Feeling isolated because others don’t understand
  • Anxiety about unpredictable reactions
  • Grief over losing ability to eat freely, go places spontaneously
  • Frustration with invisible illness
  • Medical trauma from dismissal

Strategies:

  • Connect with online MCAS communities
  • Therapy with provider who understands chronic illness
  • Practice self-compassion
  • Educate close friends and family
  • Advocate for yourself without apologizing

See Mental Health and For Allies.


MCAS is controversial enough that dismissal is common:

  • Told “it’s just anxiety” when anxiety is a symptom of mast cell mediator release
  • Told “you have too many symptoms” (when multi-system involvement is the nature of MCAS)
  • Told “that’s not a real condition”
  • Told to “just avoid triggers” when triggers are unavoidable or unpredictable

Your symptoms are real. The controversy is about diagnostic criteria, not whether mast cell activation occurs.

With doctors:

  • Bring symptom records and documentation
  • Bring peer-reviewed articles if doctor is unfamiliar (patient organizations provide these)
  • Ask for trial of H1 + H2 antihistamines even if testing isn’t conclusive
  • Request referral to allergist or specialist
  • If dismissed, request it be documented in your record

Choosing providers:

  • Look for doctors who are “curious” rather than dismissive
  • Specialists at academic medical centers may be more familiar
  • Patient organization provider directories are valuable
  • Sometimes a doctor who says “I don’t know much about MCAS but I’m willing to learn” is better than one who insists it doesn’t exist

Specialist Centers:

  • Academic medical centers with mast cell programs
  • Brigham and Women’s Hospital (Boston)
  • University of Michigan
  • Mayo Clinic

Patient Organizations:

  • The Mast Cell Disease Society (tmsforacure.org)—research funding, education, provider directory
  • Mast Cell Action (patient-run advocacy)

Disability Benefits: MCAS can qualify for Social Security Disability under immune system disorders (Section 14.00) if symptoms are severe and well-documented.

Documentation needed:

  • Formal diagnosis from allergist/immunologist
  • Laboratory results (even if borderline)
  • Documentation of anaphylaxis episodes
  • Records of emergency room visits
  • Medication trials and responses
  • Functional limitations

See US SSDI and US SSI.

Patient Organizations:

  • Mast Cell Action (mastcellaction.org)—UK charity run by people with lived experience; excellent resources

NHS Pathway:

  • GP referral to allergist or immunologist
  • Limited NHS doctors specializing in MCAS
  • Mast Cell Action maintains UK provider list

Disability Benefits:

  • Personal Independence Payment (PIP)—describe worst days, unpredictability of symptoms
  • Employment and Support Allowance (ESA)

See UK Benefits.

Limited specialist availability; most diagnosis by allergists in major cities.

See Canada Benefits for disability support.

Growing recognition; specialists in major cities. NDIS available for those with significant functional impairment.

See Australia Benefits.

Recognition and treatment availability varies widely. Telemedicine has expanded access to knowledgeable providers internationally.


  • Better diagnostic markers
  • Why MCAS occurs with EDS and POTS
  • Role of tryptase gene duplications (Hereditary Alpha-Tryptasemia)
  • New treatment approaches
  • Genetic factors

Most MCAS research funded by:

  • The Mast Cell Disease Society (over $500,000 in research grants)
  • Patient donations and advocacy
  • Limited government funding
  • Consensus updates on diagnostic criteria
  • Growing recognition of MCAS-EDS-POTS overlap
  • Research into biomarkers beyond tryptase

  • Reddit: r/MCAS, r/mastcelldiseases
  • Facebook: Multiple MCAS support groups
  • The Mast Cell Disease Society forums
  • Twitter/X: #MCAS, #MastCellAware
  • The Mast Cell Disease Society has regional connections
  • Mast Cell Action (UK) has local groups
  • Online communities often organize regional meetups


This page centers disabled people’s expertise and is informed by disabled-led organizing globally. For questions or to suggest additions, see How to Contribute.


Have lived experience or expertise that could strengthen this page? We especially welcome perspectives on models not well represented here, including those from the Global South and Indigenous communities.

Suggest an edit or addition →


This page centers disabled people’s expertise and is informed by disabled-led organizing globally. For questions or to suggest additions, see How to Contribute.